What is the address of SIGMADENT?

The registered office of SIGMADENT is located at Milseweg 45, 3001 Leuven.

Is SIGMADENT still active?

Yes. According to the CBE (15 November 2026) SIGMADENT is active, legal situation “Normale toestand”, started on 3 May 2010.

Is SIGMADENT registered on Peppol?

Yes, SIGMADENT is registered on the Peppol network with ID 0208:0825586497.

What is the enterprise number of SIGMADENT?

The enterprise number of SIGMADENT is BE0825586497.

When was SIGMADENT founded?

SIGMADENT was founded on 3 May 2010.

Who are the directors of SIGMADENT?

According to the 2025 annual accounts, the directors of SIGMADENT are: JAN DONCK.

Is SIGMADENT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 May 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did SIGMADENT make in 2025?

SIGMADENT posted a profit after taxes of € 20,364 in financial year 2025.

What is the revenue of SIGMADENT?

As a small company, SIGMADENT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 69,601.

SIGMADENT (Private Limited) - Leuven - BE0825586497

Q: What does SIGMADENT do?

SIGMADENT is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 3 May 2010, 2 establishments.

Dossier SIGMADENT, printed on 15 November 2026 from databakkes.be/en/0825586497/sigmadent. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SIGMADENT from Leuven, company number BE0825586497, closed financial year 2025 with a result of € 20,364 after tax. For that financial year SIGMADENT recorded a gross margin of € 69,601 and equity of € 94,903. Compared with financial year 2024, the result moved from € 36,450 to € 20,364. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Healthy

€ 94,903

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 20,364

▼ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78,010

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 32,942 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 22,979

▲ 35% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 987

▼ 80% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 1,386

▼ 75% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 26,151

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,541

▲ 204% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 48,013 Gross margin 2022: € 48,013 First fiscal year in the series	€ 56,860 Gross margin 2023: € 56,860 ▲ 18% vs 2022 (€ 48,013) Favourable step	€ 84,812 Gross margin 2024: € 84,812 ▲ 49% vs 2023 (€ 56,860) Favourable step	€ 69,601 Gross margin 2025: € 69,601 ▼ 18% vs 2024 (€ 84,812) Unfavourable step	▼ 18%
Profit after taxes	€ 16,534 Profit after taxes 2022: € 16,534 First fiscal year in the series	€ 26,144 Profit after taxes 2023: € 26,144 ▲ 58% vs 2022 (€ 16,534) Favourable step	€ 36,450 Profit after taxes 2024: € 36,450 ▲ 39% vs 2023 (€ 26,144) Favourable step	€ 20,364 Profit after taxes 2025: € 20,364 ▼ 44% vs 2024 (€ 36,450) Unfavourable step	▼ 44%
Equity	€ 64,887 Equity 2022: € 64,887 First fiscal year in the series	€ 71,031 Equity 2023: € 71,031 ▲ 9% vs 2022 (€ 64,887) Favourable step	€ 107,480 Equity 2024: € 107,480 ▲ 51% vs 2023 (€ 71,031) Favourable step	€ 94,903 Equity 2025: € 94,903 ▼ 12% vs 2024 (€ 107,480) Unfavourable step	▼ 12%
Total debts	€ 44,097 Total debts 2022: € 44,097 First fiscal year in the series	€ 63,925 Total debts 2023: € 63,925 ▲ 45% vs 2022 (€ 44,097) Unfavourable step	€ 66,426 Total debts 2024: € 66,426 ▲ 4% vs 2023 (€ 63,925) Unfavourable step	€ 62,078 Total debts 2025: € 62,078 ▼ 7% vs 2024 (€ 66,426) Favourable step	▼ 7%
Cash	€ 36,271 Cash 2022: € 36,271 First fiscal year in the series	€ 57,479 Cash 2023: € 57,479 ▲ 58% vs 2022 (€ 36,271) Favourable step	€ 109,804 Cash 2024: € 109,804 ▲ 91% vs 2023 (€ 57,479) Favourable step	€ 78,010 Cash 2025: € 78,010 ▼ 29% vs 2024 (€ 109,804) Unfavourable step	▼ 29%
Retained profit	€ 52,487 Retained profit 2022: € 52,487 First fiscal year in the series	€ 58,631 Retained profit 2023: € 58,631 ▲ 12% vs 2022 (€ 52,487) Favourable step	€ 95,080 Retained profit 2024: € 95,080 ▲ 62% vs 2023 (€ 58,631) Favourable step	€ 82,503 Retained profit 2025: € 82,503 ▼ 13% vs 2024 (€ 95,080) Unfavourable step	▼ 13%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 20,000) Unchanged	€ 32,942 Dividend 2025: € 32,942 Unchanged (€ 0) Unchanged
Bank debt	€ 18,626 Bank debt 2022: € 18,626 First fiscal year in the series	€ 9,437 Bank debt 2023: € 9,437 ▼ 49% vs 2022 (€ 18,626) Favourable step	€ 5,467 Bank debt 2024: € 5,467 ▼ 42% vs 2023 (€ 9,437) Favourable step	€ 1,386 Bank debt 2025: € 1,386 ▼ 75% vs 2024 (€ 5,467) Favourable step	▼ 75%
Balance sheet total	€ 108,984 Balance sheet total 2022: € 108,984 First fiscal year in the series	€ 134,955 Balance sheet total 2023: € 134,955 ▲ 24% vs 2022 (€ 108,984) Unchanged	€ 173,907 Balance sheet total 2024: € 173,907 ▲ 29% vs 2023 (€ 134,955) Unchanged	€ 156,981 Balance sheet total 2025: € 156,981 ▼ 10% vs 2024 (€ 173,907) Unchanged	▼ 10%

By gross margin, SIGMADENT ranks 4th of 5 companies with main activity “Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden” in Leuven that publish figures (fiscal year 2025).

Key figures of SIGMADENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about SIGMADENT the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to SIGMADENT?

What happened at SIGMADENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 20,364 (▼ 44% vs 2024). Source: NBB ↗
Sep 1, 2023 New establishment in Leuven. KBO
May 3, 2010 New establishment in Leuven. KBO
May 3, 2010 Start of the company according to the CBE. KBO

In short

From € 16,534 profit in 2022 to € 20,364 profit in 2025.

Paid € 39,006 in corporate taxes since 2022.

Best year ever: 2024, with € 36,450 profit.

Paid out € 52,942 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JAN DONCK

SIGMADENT

Behind SIGMADENT is JAN DONCK.

Directors

According to the 2025 annual accounts

JAN DONCK

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Milseweg 45

3001 Leuven

2.187.991.584

Koning Leopold I-straat 28 box 1

3000 Leuven

Active since 3 May 2010

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Leuven

Same main activity (Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden), 9 active companies in Leuven, largest first.

TERUMO EUROPE

€ 799.2 million revenue · 2026

MATERIALISE

€ 181 million revenue · 2025

GC Manufacturing Europe

€ 68.5 million revenue · 2026

ORTHOPEDIE VAN HAESENDONCK

€ 3.6 million gross margin · 2025

INTERPOINT

€ 129,566 gross margin · 2026

TELEMECO

€ 79,674 gross margin · 2025

All companies with this activity → Largest companies in Leuven →

Details

Company number: 0825.586.497
VAT number: BE 0825.586.497
Registered office: Milseweg 45, 3001 Leuven
Names & denominations: SIGMADENT
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 May 2010
Peppol: Active · Active since 6 Jan 2026
Activities · NACE: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

View on CBE Public ↗ Annual accounts (NBB) ↗